Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection

Jian-Hong Zhong,1,* Yang Ke,1,2,* Shao-Liang Zhu,1,* Lin Wang,2 Cheng-Piao Luo,3 Wen-Feng Gong,1 Xue-Mei You,1 Liang Ma,1 Bang-De Xiang,1 Le-Qun Li1 1Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 2Department of Hepatobiliary Surgery, The Seco...

Full description

Bibliographic Details
Main Authors: Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:OncoTargets and Therapy
Subjects:
adefovir dipivoxil
hepatitis B virus
hepatocellular carcinoma
lamivudine
radical resection
Online Access:https://www.dovepress.com/adefovir-dipivoxil-is-less-expensive-than-lamivudine-and-associated-wi-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/adefovir-dipivoxil-is-less-expensive-than-lamivudine-and-associated-wi-peer-reviewed-article-OTT

Similar Items